Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Efaproxiral reported to improve survival in cancer patients with brain metastases

July 15, 2003

Further preclinical characterization of AG-013736, a VEGFR/PDGFR TK inhibitor

July 15, 2003

Orally available Src tyrosine kinase inhibitor characterized in vitro and in vivo

July 15, 2003

Roche presents new series of antitumor agents targeting CDK2

July 15, 2003

Selective small-molecule inhibitors of CDK4 identified at Roche

July 15, 2003

AVP-893: a prototype of a novel class of antitumor agents designed at Avanir

July 15, 2003

Novel methionine aminopeptidase type 2 inhibitors discovered by GSK scientists

July 15, 2003

Optimization of CDK-2 inhibitor series as orally active antitumor agents

July 14, 2003

BMS presents second-generation farnesyltransferase inhibitors at AACR meeting

July 14, 2003

Ivax initiates phase II trial of talampanel for brain cancer

July 14, 2003

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...